Citigroup’s Elanco Animal Health ELAN Stock Holding History

Citigroup’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45,000	Closed	-$545K	–	5682
2024 Q4	$545K	Hold	45,000	–	–	﹤0.01%	3759
2024 Q3	$661K	Buy	+45,000	New	+$627K	﹤0.01%	3553
2024 Q2	–	Sell	-29,400	Closed	-$479K	–	5624
2024 Q1	$479K	Buy	+29,400	New	+$460K	﹤0.01%	3606
2023 Q4	–	Sell	-30,000	Closed	-$337K	–	5742
2023 Q3	$337K	Hold	30,000	–	–	﹤0.01%	3342
2023 Q2	$302K	Buy	+30,000	New	+$278K	﹤0.01%	3676
2021 Q1	–	Sell	-20,900	Closed	-$641K	–	6546
2020 Q4	$641K	Buy	20,900 +8,900	+74%	+$272K	﹤0.01%	3984
2020 Q3	$335K	Sell	12,000 -67,200	-85%	-$1.7M	﹤0.01%	4203
2020 Q2	$1.7M	Sell	79,200 -55,900	-41%	-$1.23M	﹤0.01%	3002
2020 Q1	$3.02M	Buy	135,100 +132,900	+6,041%	+$3.64M	﹤0.01%	2095
2019 Q4	$65K	Buy	2,200 +200	+10%	+$5.43K	﹤0.01%	6106
2019 Q3	$53K	Sell	2,000 -8,100	-80%	-$243K	﹤0.01%	6086
2019 Q2	$341K	Sell	10,100 -11,200	-53%	-$364K	﹤0.01%	4805
2019 Q1	$683K	Buy	+21,300	New	+$655K	﹤0.01%	3833

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Citigroup's ELAN Position: Q2 2026 in Review

Citigroup increased its Elanco Animal Health (ELAN) stake by 17% in Q2 2026, buying an estimated $851K and bringing the position to 257,255 shares worth $6.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

Citigroup first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $50.7M in Q1 2019. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Citigroup held 257,255 shares of Elanco Animal Health worth $6.33M as of Q2 2026.
Citigroup bought 36,803 Elanco Animal Health shares in Q2 2026, an estimated $851K.
Elanco Animal Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1945 holding.
Citigroup first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
Citigroup's Elanco Animal Health position peaked at $50.7M in Q1 2019.
522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.